Back

Effectiveness of perindopril/amlodipine fixed dose combination in hypertensive patients with coronary artery disease. A panhellenic prospective non-interventional study.

27 August 2016 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Treatment of hypertension Treatment of hypertension ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Manolis Kallistratos

Metropolitan hospital, Piraeus (Greece)

10 More presentations in this session

Presentation thumbnail
Doctor M. Hameed (Birmingham, GB)
Abstract
Presentation thumbnail
Doctor P. Brunel (Basel, CH)
Abstract Slides
Presentation thumbnail
Professor G. Radchenko (Kiev, UA)
Abstract Slides
Presentation thumbnail
Associate Professor W. Chang (Taipei, TW)
Abstract Slides
Presentation thumbnail
Professor Y. Dohi (Nagoya, JP)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Treatment of hypertension

The Event

Event poster

ESC Congress 2016

27 August 2016 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension
25 August 2023
thumbnail
Webinar
Percutaneous interventions in patients with coronary artery disease and specific clinical conditions - IC Core Curriculum 6
9 November 2022
thumbnail
Congress Presentation
Successful perindopril/amlodipine+indapamide treatment as second line in uncontrolled hypertensive patients in line with european guidelines
7 April 2022
thumbnail
Congress Presentation
Secondary prevention of coronary artery disease: a retrospective observational analysis of italian healthcare administrative data
7 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources